Novo Nordisk SG&A Expense (Quarterly) Trends

Novo Nordisk A/S (NVO)

126.92 +1.13 (+0.90%) USD | NYSE | Apr 26, 16:00

127.27 +0.35 (+0.28%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2004. Upgrade now.

Date	Value
December 31, 2023	2.688B
September 30, 2023	2.055B
June 30, 2023	2.253B
March 31, 2023	1.944B
December 31, 2022	2.075B
September 30, 2022	1.707B
June 30, 2022	1.694B
March 31, 2022	1.682B
December 31, 2021	1.972B
September 30, 2021	1.608B
June 30, 2021	1.443B
March 31, 2021	1.489B
December 31, 2020	1.756B
September 30, 2020	1.442B
June 30, 2020	1.215B
March 31, 2020	1.257B
December 31, 2019	1.597B
September 30, 2019	1.306B
June 30, 2019	1.269B
March 31, 2019	1.196B
December 31, 2018	1.528B
September 30, 2018	1.257B
June 30, 2018	1.272B
March 31, 2018	1.207B
December 31, 2017	1.489B

Date	Value
September 30, 2017	1.168B
June 30, 2017	1.126B
March 31, 2017	1.103B
December 31, 2016	1.316B
September 30, 2016	1.181B
June 30, 2016	1.175B
March 31, 2016	1.131B
December 31, 2015	1.350B
September 30, 2015	1.177B
June 30, 2015	1.194B
March 31, 2015	1.060B
December 31, 2014	1.300B
September 30, 2014	1.204B
June 30, 2014	1.168B
March 31, 2014	1.081B
December 31, 2013	1.379B
September 30, 2013	1.129B
June 30, 2013	1.165B
March 31, 2013	1.120B
December 31, 2012	1.249B
September 30, 2012	1.018B
June 30, 2012	1.033B
March 31, 2012	992.02M
December 31, 2011	1.143B
September 30, 2011	1.045B

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.215B

Minimum

Jun 2020

2.688B

Maximum

Dec 2023

1.708B

Average

1.682B

Median

Mar 2022

SG&A Expense (Quarterly) Benchmarks